NYXH · Nyxoah SA
$1.62
+0.04 (+2.53%)
At close · Aug 14
Market Cap
$162.12M
Shares
100.07M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.62
Open$1.65
Day$1.57–1.65
52W close$1.31–6.80
Avg vol 30d172K
Short int439K · 0.4% float · 3.4d
Short vol45%
Last earningsAug 5, 2026
DataApr 2021–Aug 2026
Up next
Next earnings call
Nov 2, 2026
Est · unconfirmed
· in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−53%
below
Price vs 50-day avg
+3%
above
RSI (14)
55
neutral
MACD trend
Positive
52-week position
6%
near low
Volume (OBV)
Bearish div.
distributing
Momentum
relative strength
1-month return
+3%
trailing
6-month return
−63%
trailing
YTD return
−65%
this year
Relative strength
−77%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+32% holders QoQ · +20 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.44% of float · ▲ +6.2% MoM · 3.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
45 holders — near 3-yr high, broad support
Squeeze score
46
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
82%
annualized · 1-yr
Max drawdown
−81%
past year
ATR
5.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jun 30, 2026
Gross margin
· full year 2026
60% – 62%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−53%
Bearish
Price vs 50-day avg
+3%
Bullish
RSI (14)
55
Neutral
MACD trend
Positive
Bullish
52-week position
6%
Bearish
Volume (OBV)
Bearish div.
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+32% holders QoQ · +20 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.44% of float · ▲ +6.2% MoM · 3.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
45 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $1
Now $2 · 6%
Range high $7
vs 200-day avg -53%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NYXH
this stock
Nyxoah SA
|
$162.12M | -64.8% | — | — | 0.4% |
|
ISRG
Intuitive Surgical Inc
|
$139.37B | -30.3% | +20.5% | 45.3 | 1.9% |
|
BDX
Becton Dickinson & Co
|
$49.96B | — | +8.2% | — | 3.7% |
|
MDLN
Medline Inc.
|
$46.99B | -14.9% | +11.5% | — | 2.6% |
|
ALC
Alcon Inc
|
$35.89B | -5.8% | +10.5% | — | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NYXH | +10.2% | +3.2% | -63.4% | +15.7% | -64.8% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | +9.8% | -1.3% | -77.2% | +11.8% | -78.6% |
Key facts
CIK
1857190
CUSIP
B6S7WD106
13F (30d)
45 filings
45 filers
Visit website
Investor relations